Middle East and Africa Veterinary Vaccines Market
Middle East and Africa Veterinary Vaccines Market Size Expands at CAGR of 5.42% to Cross USD 648 Million by 2030
Published | 31 January 2024
Middle East and Africa Veterinary Vaccines Market is propelled by growing awareness about animal health, increasing pet ownership, rising incidence of zoonotic diseases, government initiatives for animal vaccination, and advancements in veterinary healthcare.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Middle East and Africa Veterinary Vaccines Market size at USD 472.06 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Middle East and Africa Veterinary Vaccines Market size to grow at a CAGR of 5.42% reaching a value of USD 648.06 million by 2030. The Middle East and Africa Veterinary Vaccines Market is propelled by rising awareness about animal health, growing livestock population, and the prevalence of infectious diseases. A growing demand for protein-rich food products and the need to enhance agricultural productivity contribute to the market expansion. Government initiatives to control and prevent animal diseases, coupled with advancements in biotechnology, further drive vaccine adoption. Additionally, a surge in companion animal ownership and the emergence of zoonotic diseases underscore the importance of veterinary vaccines, fostering market growth in Middle East and Africa.
Opportunity – Increasing demand for organic and sustainable livestock production
The Middle East and Africa Veterinary Vaccines Market is propelled by the burgeoning demand for organic and sustainable livestock production. As consumers prioritize healthier and ethically sourced animal products, the market experiences a surge in demand for veterinary vaccines that support sustainable farming practices. The shift toward organic livestock production ensures the well-being of animals and also emphasizes the importance of disease prevention, driving the adoption of advanced veterinary vaccines in the region.
Impact of Escalating Geopolitical Tensions on Middle East and Africa Veterinary Vaccines Market
The escalating geopolitical tensions in the Middle East and Africa have added a layer of uncertainty and volatility to the Veterinary Vaccines Market in the region, further compounded by the Israel-Hamas conflict and Russia-Ukraine war. Economic sanctions and geopolitical challenges have created ripple effects across industries, influencing consumer sentiment and purchasing behaviors. In the context of recent tensions between Israel and its neighbors, various industries face potential revenue impacts. However, the Israeli government's strong focus on national security, including biosecurity, highlights the crucial role of the veterinary vaccines sector. Despite broader economic challenges, the market remains essential for preserving animal populations, ensuring food security, and preventing bioterrorism. In navigating these complex dynamics, businesses must adopt agile and responsive veterinary vaccine strategies to address evolving consumer preferences and geopolitical landscape.
Sample Request @ https://www.blueweaveconsulting.com/report/middle-east-and-africa-veterinary-vaccines-market/report-sample
Middle East and Africa Veterinary Vaccines Market
Segmental Coverage
Middle East and Africa Veterinary Vaccines Market – By Type
Based on type, Middle East and Africa Veterinary Vaccines Market is divided into Poultry Vaccine, Livestock Vaccines (Bovine Vaccines and Small Ruminant Vaccines) Companion Animal Vaccines (Feline Vaccines and Canine Vaccines), and Aquaculture Vaccine segments. The livestock vaccines segment, encompassing bovine vaccines and small ruminant vaccines segment is the largest in the Middle East and Africa Veterinary Vaccines Market. The segment plays a pivotal role in safeguarding the health of cattle and small ruminants, contributing significantly to the overall veterinary vaccine market in the region. With a focus on livestock health and welfare, these vaccines address the unique needs of bovine and small ruminant populations, reflecting the importance of the agricultural and farming sectors in the Middle East and Africa.
Middle East and Africa Veterinary Vaccines Market – By Technology
By technology, the Middle East and Africa Veterinary Vaccines Market is divided into Live Attenuated Vaccines, Inactivated Vaccines (Toxoid Vaccines and Recombinant Vaccines), and Conjugate Vaccines segments. The inactivated vaccines segment, further categorized into toxoid vaccines and recombinant vaccines segments dominates the market share. The segment involves vaccines that are either deactivated or genetically engineered, offering a wide range of applications in veterinary medicine. Inactivated vaccines are crucial in preventing diseases among animals, and the toxoid and recombinant subcategories highlight the advanced technologies employed for heightened efficacy. The segment's prominence underscores the region's emphasis on innovative veterinary healthcare solutions, contributing significantly to the overall market landscape.
Competitive Landscape
Middle East and Africa Veterinary Vaccines Market is fiercely competitive. Major companies in the market include BIOVAC, Boehringer Ingelheim International GmbH, Ceva, Elanco, Hester Biosciences Limited, Merck & Co., Inc., NEOGEN Corporation, Virbac, and Zoetis Inc. These companies use various strategies, including increasing investments in their R&D activities, mergers, and acquisitions, joint ventures, collaborations, licensing agreements, and new product and service releases to further strengthen their position in the Middle East and Africa Veterinary Vaccines Market.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Middle East and Africa Veterinary Vaccines Market. It also highlights the factors driving forecasts of total Market size. The report promises to provide recent technology trends in Middle East and Africa Veterinary Vaccines Market and industry insights to help decision-makers make sound strategic decisions. Further, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
About Us
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing both qualitative and quantitative data to boost the performance of your business solutions. BlueWeave has built its reputation by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
Contact Us:
BlueWeave Consulting & Research Pvt Ltd
+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662
Get Help
Related Report
Publish Date: January 2024
Increasing prevalence of infectious diseases among growing livestock population, rising awareness about animal health, and governments’ supportive initiatives are key driving factors propelling the growth of the Middle East and Africa Veterinary Vaccines Market during the forecast period between 2024 and 2030.
Relevant Press Releases
- India Contraceptives (Drugs & Devices) Market to Grow at 8.5% CAGR between 2022 and 2028
- Global External Defibrillator Market to Reach USD 7.5 Billion by 2028
- Global Medication Adherence Market to Surpass USD 5.5 Billion Mark by 2028
- Global Laparoscopy and Endoscopy Devices Market to Grow at a CAGR of 7.8%, during Forecast Period
- Global Microbiome Therapeutics Market to Boom at Robust CAGR to Cross USD 746 Million by 2028